Bankrupt Savient Takes $120M Bid From Pharma Co. Crealta
Cash-strapped Savient filed for Chapter 11 in October after lining up a unit of US WorldMeds LLC as a $55 million stalking horse and tapped Crealta as the winning bidder Tuesday following a successful Section 363 sale, according to a joint release.
Crealta — a recently minted partnership between Chicago-based private equity firm GTCR and Ed...
Already a subscriber? Click here to login